Abstract
Statins are widely used for primary and secondary prevention of cardiovascular disease. Several large clinical trials have demonstrated that by lowering LDL-cholesterol clinical events (eg myocardial infarction, stroke, and vasuclar death) can be reduced when statins are commenced in most patients without contraindications who have established cardiovascular disease.
| Original language | English |
|---|---|
| Pages (from-to) | 66-71 |
| Number of pages | 6 |
| Journal | Australian Pharmacist |
| Volume | 32 |
| Issue number | 11 |
| Publication status | Published - 2013 |
